H-1B sponsorship profile: Audentes Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, Audentes Therapeutics Inc filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Audentes Therapeutics Inc’s H-1B petitions range from $76,461 at the low end to $145,500 at the high end, with a petition-weighted average of $114,654. That range reflects the mix of occupations the company sponsors, led by Validation Engineer (1 petitions at $122,000 avg), followed by Research Associate II, Vector Production and Associate Director, Gene Therapy Competitive Intelligence . H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Audentes Therapeutics Inc is headquartered in Northbrook, IL under NAICS code 54171, and places H-1B workers across 2 states, most heavily in CA, NC. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Audentes Therapeutics Inc ranks. By H-1B petition volume, Audentes Therapeutics Inc is #37,433 of 119,880 employers nationally and #1,789 of 5,284 employers headquartered in IL. Both ranks are computed live from the same underlying petition counts, not a separate estimate.